Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
Clinical trial NCT05817227 · RECRUITING
Trial details
- NCT number
- NCT05817227
- Sponsor
- National Cancer Institute, Naples
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-19
- Primary completion
- 2027-11-19
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.